Current Psychiatry Reports

, Volume 10, Issue 5, pp 419–423

Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: An evolving picture



Despite the increasing recognition of attention-deficit/hyperactivity disorder (ADHD) in females, gender-sensitive comorbidity profiles have been slow to develop. In this article, I focus on coexisting conditions in females with ADHD and highlight significant differences that deserve greater attention. For some time, it has been held that women with ADHD are more likely to internalize symptoms and become anxious and depressed and to suffer emotional dysregulation than males with the disorder. Recent evidence confirms that girls with ADHD are 5.4 times more likely to be diagnosed with major depression and three times more likely to be treated for depression before their ADHD diagnosis. I also discuss eating disorders (particularly binge eating and bulimia) that recently have been linked to ADHD in girls and women. The disordered eating/ADHD connection is not difficult to understand but has important clinical and therapeutic implications that must not be overlooked.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kessler R, Adler L, Barkley R, et al.: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2007, 163: 716–723.CrossRefGoogle Scholar
  2. 2.
    Froehlich TE, Lanphear BP, Epstein JN, et al.: Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007, 61: 857–864.CrossRefGoogle Scholar
  3. 3.
    Walker C: Gender and genetics in ADHD: genetics matter; gender does not. Paper presented at the ADDA Conference, Chicago; 1999.Google Scholar
  4. 4.
    Faraone SV, Biederman J, Spencer T, et al.: Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48: 9–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Robison RJ, Reimherr F, Faraone SV, et al.: Gender differences in ADHD adults during clinical trials with atomoxetine [poster NR 497]. Program and Abstracts of the American Psychiatric Association 2005 Annual Meeting. Atlanta: American Psychiatric Association; 2005.Google Scholar
  6. 6.
    Robison RJ, Reimherr F, Marchant MS, et al.: Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. J Clin Psychiatry 2008, 69: 213–217.PubMedCrossRefGoogle Scholar
  7. 7.
    Biederman J, Faraone SV, Monuteaux MC, et al.: Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry 2004, 55: 692–700.PubMedCrossRefGoogle Scholar
  8. 8.
    Shekim W, Asarnow RF, Hess E, et al.: An evaluation of attention deficit disorder-residual type. Compr Psychiatry 1990, 31: 416–425.PubMedCrossRefGoogle Scholar
  9. 9.
    Wilens TE, Biederman J, Spencer TJ: Attention-deficit/hyperactivity disorder across the lifespan. Annu Rev Med 2002, 53: 113–131.PubMedCrossRefGoogle Scholar
  10. 10.
    Rucklidge JJ, Tannock R: Psychiatric, psychosocial, and cognitive functioning of female adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 2001, 40: 530–540.PubMedCrossRefGoogle Scholar
  11. 11.
    Biederman J, Ball SW, Monuteaux MC, et al.: New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry 2008, 47: 426–434.PubMedCrossRefGoogle Scholar
  12. 12.
    Hinshaw SP, Owens EB, Sami N, Fargeon S: Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: evidence for continuing cross-domain impairment. J Consult Child Psychol 2006, 74: 489–499.CrossRefGoogle Scholar
  13. 13.
    Turgay A, Ansari R, Schwartz M, et al.: Comorbidity differences in ADHD throughout the life cycle. Program and Abstracts of the American Psychiatric Association. Toronto: American Psychiatric Association; 2006.Google Scholar
  14. 14.
    Biederman J, Monuteaux MC, Mick E, et al.: Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry 2006, 60: 1098–1105.PubMedCrossRefGoogle Scholar
  15. 15.
    Quinn P, Wigal S: Perceptions of girls and ADHD: results from a national survey. MedGenMed 2004, 6: 2. Accessed May 4, 2004.PubMedGoogle Scholar
  16. 16.
    Surman C, Randall E, Biederman J: Is there an association between ADHD and bulimia? J Clin Psychiatry 2006, 67: 351–354.PubMedCrossRefGoogle Scholar
  17. 17.
    Biederman J, Ball SW, Monuteaux MC: Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr 2007, 28: 302–307.PubMedCrossRefGoogle Scholar
  18. 18.
    Mikami AY, Hinshaw SP, Patterson KA, Lee JC: Eating pathology among adolescent girls with attention-deficit/hyperactivity disorder. J Abnorm Psychol 2008, 117: 225–235.PubMedCrossRefGoogle Scholar
  19. 19.
    Schweickert LA, Strober M, Moskowitz A: Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report. Int J Eat Disord 1997, 21: 299–301.PubMedCrossRefGoogle Scholar
  20. 20.
    Sokol MS, Gray NS, Goldstein A, et al.: Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder. Int J Eat Disord 1999, 25: 233–237.PubMedCrossRefGoogle Scholar
  21. 21.
    Dukarm C: Bulimia nervosa and ADD: a possible role for stimulant medication. J Womens Health 2005, 14: 345–350.CrossRefGoogle Scholar
  22. 22.
    Dukarm C: Pieces of the Puzzle: A Link Between Eating Disorders and AD/HD. Washington, DC: Advantage Books; 2006.Google Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.National Center for Girls and Women with ADHDWashington, DCUSA

Personalised recommendations